Risk factors for fibrocystic breast disease and its histopathologic components
- PMID: 3859695
Risk factors for fibrocystic breast disease and its histopathologic components
Abstract
The relationship between various sociodemographic, reproductive, and other factors to the occurrence of fibrocystic breast disease was evaluated in a case-control study undertaken at five Connecticut hospitals from 1979 to 1981. The study groups comprised 590 women with biopsy-proven fibrocystic breast disease and 1,018 women with other surgical conditions. Among the premenopausal women, multivariate analysis suggested that high socioeconomic status, Jewish religion, low parity, a history of benign breast disease, a history of breast cancer in the mother or a sister, and low Quetelet index were associated with increased odds ratios (OR) for fibrocystic breast disease. Similar analysis for the postmenopausal women revealed increased OR for women with high socioeconomic status, a late age at menopause, and a history of benign breast disease. Current smokers as well as those who had had a tubal sterilization had significantly reduced odds of fibrocystic disease. There was no convincing evidence of linear trends according to degree of epithelial atypia for any of the variables considered. Although some variation in the OR emerged in the analysis according to selected histologic components, the results provided little evidence that women with biopsy specimens exhibiting gross cysts, sclerosing adenosis, papillary hyperplasia, or papillomatosis showed epidemiologic similarities with breast cancer patients.
Similar articles
-
Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study.J Natl Cancer Inst. 1984 May;72(5):1015-9. J Natl Cancer Inst. 1984. PMID: 6585579
-
Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.J Natl Cancer Inst. 1983 Jul;71(1):5-9. J Natl Cancer Inst. 1983. PMID: 6575209
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
Epidemiology of susceptibility to breast cancer.Prog Clin Biol Res. 1996;395:159-74. Prog Clin Biol Res. 1996. PMID: 8895988 Review.
-
Use of risk factors in counseling patients.Hematol Oncol Clin North Am. 1989 Dec;3(4):599-610. Hematol Oncol Clin North Am. 1989. PMID: 2691491 Review.
Cited by
-
Risk factors for histologically confirmed benign breast tumors.Eur J Epidemiol. 1994 Jun;10(3):259-65. doi: 10.1007/BF01719347. Eur J Epidemiol. 1994. PMID: 7859835
-
Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer.Jpn J Cancer Res. 1998 Feb;89(2):116-23. doi: 10.1111/j.1349-7006.1998.tb00538.x. Jpn J Cancer Res. 1998. PMID: 9548437 Free PMC article.
-
The comparison of the effect of flaxseed oil and vitamin E on mastalgia and nodularity of breast fibrocystic: a randomized double-blind clinical trial.J Pharm Health Care Sci. 2021 Jan 6;7(1):4. doi: 10.1186/s40780-020-00186-4. J Pharm Health Care Sci. 2021. PMID: 33407941 Free PMC article.
-
Atypical hyperplasia and breast cancer risk: a critique.Cancer Causes Control. 1992 Nov;3(6):517-25. doi: 10.1007/BF00052748. Cancer Causes Control. 1992. PMID: 1420854
-
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.PLoS One. 2015 Jun 22;10(6):e0129500. doi: 10.1371/journal.pone.0129500. eCollection 2015. PLoS One. 2015. PMID: 26098961 Free PMC article.